98%
921
2 minutes
20
Background: A substantial cohort of individuals rely on online resources, such as discussion forums, for support on tapering antidepressants. This study aimed to assess the performance of generative artificial intelligence (AI) in responding to clinical queries on tapering antidepressants.
Methods: Ten queries on tapering antidepressants were developed based on previous research, prescribing guidelines, and online peer support forums. Queries covered areas including reasons for discontinuing antidepressants, tapering methods, withdrawal symptoms, and relapse. Each query was submitted to ChatGPT (OpenAI, San Francisco, CA) using the GPT-4 model as an independent standalone query using standardised prompts. Responses were evaluated in terms of relevance, accuracy, completeness, and clarity by two researchers working independently.
Results: GPT-4 responses to all tapering queries were considered relevant and within scope. Most responses (8/10) incorporated safety netting by emphasising the importance of consulting healthcare professionals before making any medication changes. The overall accuracy, completeness, and clarity of responses compared less favourably. The response to a query on hyperbolic tapering had the least favourable assessment. This was due to inaccuracies as the response incorrectly referred to logarithmic reductions and provided inaccurate examples of fixed dosage reductions. Several instances of AI hallucinations were identified, including fabricated references.
Conclusion: Generative AI is having a transformative impact on healthcare, including how healthcare professionals and patients access information about clinical queries, such as antidepressant tapering. The study findings show that GPT-4 was able to provide relevant and safety-conscious responses on antidepressant tapering. However, performance issues such as inconsistencies and inaccuracies in tapering recommendations highlight the important role that healthcare professionals continue to play in providing patients with clinically trained, professional support in safely managing health-related issues. Further research on developing AI evaluation tools is needed to ensure consistency in the approaches used in evaluating the performance of AI in addressing clinical queries.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.sapharm.2025.06.107 | DOI Listing |
JTO Clin Res Rep
October 2025
Division of Hematology/Oncology, Department of Medicine, University of California Davis, Sacramento, California.
Objectives: Despite advances, lung cancer treatment remains associated with substantial toxicity. Early-phase clinical trials inform the safety and efficacy of novel lung cancer treatments. Although older adults represent most patients with lung cancer, and they are underrepresented in phase 3 trials, age disparity in early-phase lung cancer trials is ill-defined.
View Article and Find Full Text PDFJ Robot Surg
September 2025
Department of Gynecologic Oncology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA.
This study was conducted to investigate the techniques and complications of enlarged uterine extraction during minimally invasive surgery for uterine malignancy. The electronic medical record was queried for patients with uterine malignancy and enlarged uterus (≥ 250 g) who underwent primary hysterectomy with laparoscopic or robotic approach. Statistical analysis was performed using Fisher's exact test for categorical variables and Kruskal-Wallis test for continuous variables.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
September 2025
Department of Surgery, Mannheim School of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Purpose: The study aims to compare the treatment recommendations generated by four leading large language models (LLMs) with those from 21 sarcoma centers' multidisciplinary tumor boards (MTBs) of the sarcoma ring trial in managing complex soft tissue sarcoma (STS) cases.
Methods: We simulated STS-MTBs using four LLMs-Llama 3.2-vison: 90b, Claude 3.
J Assist Reprod Genet
September 2025
Bahçeci Fulya IVF Center, Infertility Clinic, Istanbul, Turkey.
Purpose: To assess the intra-individual variability of serum progesterone (P) levels on embryo transfer (ET) day, when the same dose of intramuscular progesterone (IM-P) was used in two consecutive hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles.
Methods: A total of 75 patients undergoing two consecutive HRT-FET cycles in one year performed at Bahceci Ankara IVF Center between November 2019 and February 2022 were retrospectively analyzed. Serum P levels were measured at the 117th-119th hours of support by a single laboratory.
Sci Prog
September 2025
Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
BackgroundGlaucoma is recognized as the second-leading cause of complete blindness in developed countries and a significant contributor to irreversible vision loss worldwide. Understanding the potential genetic links between neurodegenerative diseases, such as Parkinson's disease, and glaucoma is crucial for developing preventive strategies.MethodsThis study utilized data from Genome-Wide Association Studies databases, focusing on European populations without gender restrictions.
View Article and Find Full Text PDF